Bibliographic information
Recommendation
The World Health Organization (WHO) recommends, in hospitalized patients with COVID-19, without an established indication for higher dose anticoagulation, we suggest administering standard thromboprophylaxis dosing of anticoagulation rather than therapeutic or intermediate dosing.
Recommended in favor
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Living guidance for clinical management of COVID-19: living guidance, 23 November 2021.
Clinical management of COVID-19: living guideline, 23 June 2022.
Clinical management of COVID-19: living guideline, 15 September 2022.
Clinical management of COVID-19: living guideline, 13 January 2023.
Clinical management of COVID-19: living guideline, 18 August 2023